BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
409.4649822
NSE Symbol
NATCOPHARM
Divident Yield %
0.61
Market Cap
(Rs In Cr.)
17,674
P/E (TTM)
9.55
EPS (TTM)
103.31
Face Value
(Rs)
2
Date Heading
01-Jul-25 Natco Pharma Ltd - Natco Pharma Limited - Change in Director
30-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Retirement
27-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Trading Window
26-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Trading Window
20-Jun-25 Natco Pharma receives seven observations from USFDA Following Inspecti
20-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Other General Purpose
19-Jun-25 Natco Pharma Ltd - Intimation Under Regulation 30 Of SEBI (Listing Obl
17-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Appointment
16-Jun-25 Indices edge higher in early trade; breadth positive
16-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Updates
14-Jun-25 NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation p
13-Jun-25 Natco Pharma's Mekaguda API unit completes USFDA inspection
12-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Analysts/Institutional Inves
12-Jun-25 Natco Pharma Ltd - Natco Pharma Limited - Analysts/Institutional Inves
11-Jun-25 Natco Pharma Ltd gains for third consecutive session
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)